Current shortage status of other GLP-1 products (as of December 19, 2024): FDA continues to actively monitor drug availability and is currently working to determine whether the demand or projected demand for each drug in shortage exceeds the available supply
While GLP-1 injections are primarily prescribed for weight loss, they also support better blood sugar regulation, improve cardiovascular health, and can reduce risk factors for conditions like type 2 diabetes
Understanding why dose adherence matters helps you make informed decisions about your GLP-1 therapy
While this is beneficial for weight loss, consuming fewer calories than your body needs can temporarily result in lower energy levels
Most cases remain mild and manageable, though higher doses may increase the likelihood of experiencing this side effect
But state law can override federal rules